Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health…. Read More ›
NIAID
Gene-based Zika vaccine is safe and immunogenic in healthy adults
Vaccine developed by NIH scientists shows promise in Phase 1 testing. Results from two Phase 1 clinical trials show an experimental Zika vaccine developed by government scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the… Read More ›